GRAIL Inc GRAL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
The Gross Law Firm Reminds GRAIL, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 4, 2026 - GRAL
-
GRAL Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against Grail, Inc.
-
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit
-
Rosen Law Firm Urges GRAIL, Inc. (NASDAQ: GRAL) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
-
SHAREHOLDER CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Deadline on August 4, 2026
-
Investor Notice: Robbins LLP Informs Investors of the Grail, Inc. Class Action Lawsuit
-
GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting
Trading Information
- Previous Close Price
- $61.52
- Day Range
- $57.79–63.05
- 52-Week Range
- $29.95–118.84
- Bid/Ask
- $57.00 / $61.50
- Shares Outstanding
- 42.92M
- Market Cap
- $2.61B
- Volume/Avg
- 825 / 817,363
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 14.95
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 910
- Website
- https://www.grail.com
Valuation
|
Metric
|
GRAL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.00 |
Price/Sales | 14.95 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
GRAL
|
|---|---|
Quick Ratio | 11.29 |
Current Ratio | 11.74 |
Interest Coverage | — |
Quick Ratio
GRAL
Profitability
|
Metric
|
GRAL
|
|---|---|
Return on Assets (Normalized) | −11.60% |
Return on Equity (Normalized) | −13.36% |
Return on Invested Capital (Normalized) | −13.95% |
Return on Assets
GRAL
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Dsvzzlpr | Kkphg | $184B | |||
| Danaher Corp
DHR
| Dqbjcxfz | Yrypm | $133B | |||
| IDEXX Laboratories Inc
IDXX
| Vtfqnxprsr | Sjyct | $46B | |||
| Agilent Technologies Inc
A
| Jddgknxcn | Hqjr | $38B | |||
| Waters Corp
WAT
| Jdlcynz | Zylv | $36B | |||
| IQVIA Holdings Inc
IQV
| Dtngwkq | Zwqqs | $31B | |||
| Illumina Inc
ILMN
| Nbsskmhs | Dddjcz | $24B | |||
| Mettler-Toledo International Inc
MTD
| Qmmhhbjnh | Wrgdzhy | $23B | |||
| Quest Diagnostics Inc
DGX
| Npzqpzt | Srljw | $23B | |||
| Labcorp Holdings Inc
LH
| Qkywgknj | Vblsdj | $22B |
United States